Product Ecosystem

Our Therapeutic Pipeline

A portfolio of next-generation stem cell therapies advancing from laboratory discovery through clinical development—each addressing a critical unmet medical need in regenerative medicine. Our products are developed under rigorous GMP conditions, built on a platform of proprietary cell-programming technologies.

8

Active Products

2

In Sample Testing

4

In Scale-Up

12

Research Partners

D-Qure wound healing spray logo
D-Qure™
Herbal Wound Healing

D-Qure™ was developed as a spray formulation using key plant-derived exosomes. The product was evaluated through personal-use testing by more than eight hundred patients, suffering from difficult-to-heal chronic wounds across different ethnic groups and multiple countries.

Users voluntarily shared daily wound-treatment photographs, allowing CDH to closely monitor outcomes and continuously refine the formulation.

Key Attributes

D-Qure is now offered as a herbal extract, composed of plant-derived exosomes.

  • Natural and non-animal based
  • Free from genetic modification
  • Manufactured in a cGMP-certified facility
Images of chronic wounds treated with D-Qure are available for reference.
Plant exosome-based Vascular wounds Diabetes-caused wounds Pressure ulcers
Development Progress
Lab Trials
Complete
Sample Testing
Complete
Scale-Up
Complete
Open D-Qure e-brochure
Find out about our current product helping rapidly close chronic wounds caused by Diabetes, with remarkable results
Centilex-D eczema treatment cream logo
Centilex-D
Eczema Care Plant Exosome Cream

Our pre-optimized plant-based exosome formulations have been tested for managing eczema-related symptoms, including:

  • Rashes
  • Itchiness
  • Dry skin
  • Small pimple-like eruptions

Results so far indicate a reduction in rashes and itchiness within one week. In some cases, improvements have been observed as early as by the third application. Noticeable relief from dryness and irritation has been reported by many.

The eczema cream has completed laboratory testing and is currently undergoing cGMP scale-up and validation. Currently under discussion with Singapore hospital group of Dermatologists on clinical pathway, and working on patent filing.

Key Attributes
  • Fast action to reduce Erythema and rashes
  • Bacterial colonic control
  • Rapid therapeutic action
  • Higher moisture retention period
Plant exosome-based
Centilex-D eczema treatment cream product photo
Development Progress
Lab Trials
Complete
Sample Testing
Complete
Scale-Up
Complete
CLOZ— Natural Healing —
CLOZ
Wound Management

CLOZ was developed using a similar approach to D-Qure™, with a specific focus on pressure ulcers (bedsores).

The formulation was tested both in laboratory settings and by voluntary personal-use users. Feedback indicated:

  • Noticeable reduction in bedsore size within one week
  • Complete wound closure in approximately one month in many cases

We anticipate launching CLOZ soon.

Key Attributes
  • Easy application by home care nurses or self-usage on Bedsore (pressure ulcer) and other wounds
  • Able to use for routine maintenance of wounds of those unable go to hospital or a clinic
  • Reduction in wound size rapidly noticeable upon regular usage
  • Fast closing for Acute wounds while slow closing of wound might be noticed on big wounds such as Diabetic Foot Ulcer (DFU)
  • This product is targetted to help patients for whom hospital or clinic access is limited
  • Recommended “household” brand for wounds.
Herbal-Based Rapid Recovery No side effects Can be used on Chronic and Acute Wounds
Development Progress
Lab Trials
Complete
Sample Testing
In Progress
Scale-Up
Pending

"We are constantly developing innovative products to address unmet needs and make advanced healthcare accessible to all."

Cell Differentiation Hub
Full Portfolio

Product Pipeline Overview

A consolidated view of all products currently in development and approaching market readiness, including stage progression, therapeutic focus, and projected timelines.

Product Type Target Condition Stage Progress Status Est. Scale-Up
D-Qure Spray Advanced chronic wound healing
Ready to launch Completed
Centilex-D Cream Eczema (AD) treatment
Pre-clinical evaluation Q2 2027
CLOZ Spray Advanced wound healing and pressure ulcer care
Ready for commercial discussions Q3 2026
UCII-Collagen+Exosome Tablets Knee pain and arthritis
In scale-up stage Q3 2027
UCII-Collagen+Double Exo Tablets
In scale-up stage Q3 2027
ECZI Cream Eczema relief—personal care
Under GMP submission Q2 2026
Burn-Care Cream Mild to severe burns—personal care
GMP manufacturing Q3 2026